Evidence map›Paper›PMID 25149652›Full record

ArticleDocumenta ophthalmologica. Advances in ophthalmology2014

Recoverin-associated retinopathy secondary to Warthin tumor of parotid gland.

Shigeki Machida, Hiroshi Ohguro, Kazunori Ishida, Masamichi Suzuki, Kazuaki Kawagishi

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Documenta ophthalmologica. Advances in ophthalmology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shigeki MachidaDepartment of Ophthalmology, Dokkyo Medical University Koshigaya Hospital, 2-1-50 Minami-Koshigaya, Koshigaya, Saitama, 343-8555, Japan, machidas@dokkyomed.ac.jp.
Hiroshi Ohguro
Kazunori Ishida
Masamichi Suzuki
Kazuaki Kawagishi
Iwate Medical University · JPSapporo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo present a case of photoreceptor degeneration associated with a benign Warthin tumor of the parotid gland. CASE REPORT: A 57-year-old man visited our clinic complaining of blurred vision in both eyes. His best-corrected visual acuity was 0.07 in the right and 0.04 in the left eyes. All components of the full-field electroretinograms (ERGs) were reduced in both eyes. The focal macular ERGs were extinguished in both eyes, which was consistent with the deterioration of the outer retina in optical coherence tomographic images. Positron emission tomography showed (18)F-fluorodeoxy glucose accumulation in the left parotid gland. Parotidectomy was performed, and the histopathology of the specimen had features compatible with a Warthin tumor without malignancy. Western blot analysis of the patient's sera detected an antibody against recoverin. In addition, the tumor tissue had an aberrant expression of recoverin.

conclusionThe findings in this case indicate that recoverin-associated retinopathy can develop secondary to a benign Warthin tumor.

Indexed as

AdenolymphomaAutoantibodiesBlotting, WesternElectroretinographyFluorescein AngiographyFluorodeoxyglucose F18HumansMaleMiddle AgedParaneoplastic Syndromes, OcularParotid NeoplasmsPositron-Emission TomographyRadiopharmaceuticalsRecoverinTomography, Optical CoherenceVisual Field TestsAutoantibodiesFluorodeoxyglucose F18RadiopharmaceuticalsRCVRN protein, humanRecoverin

Identifiers

PMID25149652
OpenAlexW2040696548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.